With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.18437-78-0,Tris(4-fluorophenyl)phosphine,as a common compound, the synthetic route is as follows.
General procedure: To a stirred and degassed solution of [Fe(h5-Cp)(CO)2I] (1 mmol)in dry acetone (30 mL) PR3 (1 mmol) was added. The reactionmixture was then irradiated under UV light (125 W) for 3e7 h (seebelow). The precipitate was separated by cannula-filtration and thesolvent was evaporated under vacuum. The residue was twicerecrystallized from dry dichloromethane/n-hexane and dark greenproducts are obtained.[Fe(h5-Cp)(CO)(PPh3)
18437-78-0, As the paragraph descriping shows that 18437-78-0 is playing an increasingly important role.
Reference£º
Article; Pilon, Adhan; Girio, Patricia; Nogueira, Guilherme; Avecilla, Fernando; Adams, Harry; Lorenzo, Julia; Garcia, M. Helena; Valente, Andreia; Journal of Organometallic Chemistry; vol. 852; (2017); p. 34 – 42;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate